A detailed history of Probity Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Probity Advisors, Inc. holds 40,780 shares of PFE stock, worth $1.09 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
40,780
Previous 37,605 8.44%
Holding current value
$1.09 Million
Previous $1.05 Million 12.17%
% of portfolio
0.23%
Previous 0.22%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$27.7 - $31.39 $87,947 - $99,663
3,175 Added 8.44%
40,780 $1.18 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $72,016 - $84,389
2,851 Added 8.2%
37,605 $1.05 Million
Q1 2024

May 02, 2024

SELL
$25.89 - $29.73 $854 - $981
-33 Reduced 0.09%
34,754 $964,000
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $31,068 - $40,354
-1,189 Reduced 3.3%
34,787 $1 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $70,918 - $82,897
2,210 Added 6.55%
35,976 $1.19 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $25,861 - $29,921
-716 Reduced 2.08%
33,766 $1.24 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $27,137 - $35,425
-650 Reduced 1.85%
34,482 $1.77 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $100,691 - $122,919
-2,301 Reduced 6.15%
35,132 $1.54 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $34,804 - $41,267
-748 Reduced 1.96%
37,433 $1.96 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $147,269 - $182,485
-3,219 Reduced 7.78%
38,181 $1.98 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $22,726 - $33,687
-550 Reduced 1.31%
41,400 $2.45 Million
Q3 2021

Oct 08, 2021

BUY
$39.25 - $50.42 $33,127 - $42,554
844 Added 2.05%
41,950 $1.8 Million
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $8,726 - $9,885
-243 Reduced 0.59%
41,106 $1.61 Million
Q1 2021

Apr 28, 2021

BUY
$33.49 - $37.77 $63,229 - $71,309
1,888 Added 4.78%
41,349 $1.5 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $15,525 - $18,215
-489 Reduced 1.22%
39,461 $1.45 Million
Q2 2020

Aug 03, 2020

BUY
$30.12 - $36.54 $27,409 - $33,251
910 Added 2.33%
39,950 $1.31 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $28,057 - $40,087
-1,038 Reduced 2.59%
39,040 $1.27 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $16,097 - $18,269
-489 Reduced 1.21%
40,078 $1.57 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $32,814 - $42,551
1,010 Added 2.55%
40,567 $1.46 Million
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $35,833 - $40,232
-969 Reduced 2.39%
39,557 $1.71 Million
Q1 2019

Apr 29, 2019

BUY
$37.5 - $41.2 $66,525 - $73,088
1,774 Added 4.58%
40,526 $1.72 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $47,048 - $53,640
-1,223 Reduced 3.06%
38,752 $1.69 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $26,852 - $32,569
-779 Reduced 1.91%
39,975 $1.76 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $2,242 - $2,390
-68 Reduced 0.17%
40,754 $1.48 Million
Q1 2018

Apr 16, 2018

BUY
$31.91 - $37.02 $19,337 - $22,434
606 Added 1.51%
40,822 $1.45 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $27,938 - $29,643
840 Added 2.13%
40,216 $1.46 Million
Q3 2017

Oct 27, 2017

BUY
$31.0 - $34.15 $1.22 Million - $1.34 Million
39,376
39,376 $1.41 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Probity Advisors, Inc. Portfolio

Follow Probity Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.